These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7977967)

  • 21. Frequent p53 mutations in head and neck cancer.
    Somers KD; Merrick MA; Lopez ME; Incognito LS; Schechter GL; Casey G
    Cancer Res; 1992 Nov; 52(21):5997-6000. PubMed ID: 1394225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 mutation is rare in oral mucosa brushings from patients previously treated for a head and neck squamous cell carcinoma.
    Acha-Sagredo A; Ruesga MT; Rodriguez C; Aguirregaviria JI; de Pancorbo MM; Califano JA; Aguirre JM
    Oral Oncol; 2009 Aug; 45(8):661-4. PubMed ID: 19027352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of mutant-type p53 expression in squamous cell carcinoma of the head and neck during radiation therapy and its clinical significance: comparison of an immunohistochemical method and PCR-SSCP assay.
    Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
    Oncol Rep; 1998; 5(5):1053-9. PubMed ID: 9683807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer.
    Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
    J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S104-12. PubMed ID: 9071074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region.
    Hauser U; Balz V; Carey TE; Grénman R; Van Lierop A; Scheckenbach K; Bier H
    Head Neck; 2002 Sep; 24(9):868-73. PubMed ID: 12211051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-deletion mutation of the p53 gene at exon 4 of codon 63 in the saliva of oral squamous cell carcinoma in central India: a preliminary study.
    Mewara A; Gadbail AR; Patil S; Chaudhary M; Chavhan SD
    J Investig Clin Dent; 2010 Nov; 1(2):108-13. PubMed ID: 25427266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathology of squamous carcinomas of the head and neck.
    Carter R
    Curr Opin Oncol; 1992 Jun; 4(3):485-90. PubMed ID: 1498157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.
    Nylander K; Nilsson P; Mehle C; Roos G
    Br J Cancer; 1995 Apr; 71(4):826-30. PubMed ID: 7710950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
    van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
    BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Head and neck tumor sites differ in prevalence and spectrum of p53 alterations but these have limited prognostic value.
    Bosch FX; Ritter D; Enders C; Flechtenmacher C; Abel U; Dietz A; Hergenhahn M; Weidauer H
    Int J Cancer; 2004 Sep; 111(4):530-8. PubMed ID: 15239130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenance of identical p53 mutations throughout progression of squamous cell carcinomas of the tongue.
    Burns JE; McFarlane R; Clark LJ; Mitchell R; Robertson G; Soutar D; Parkinson EK
    Eur J Cancer B Oral Oncol; 1994 Sep; 30B(5):335-7. PubMed ID: 7703803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck.
    Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M
    Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular screening. Prospects for a new approach.
    Sidransky D; Boyle J; Koch W
    Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1187-90. PubMed ID: 8217077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis.
    Shin DM; Kim J; Ro JY; Hittelman J; Roth JA; Hong WK; Hittelman WN
    Cancer Res; 1994 Jan; 54(2):321-6. PubMed ID: 8275461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
    González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
    Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
    van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
    J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor markers in squamous cell carcinoma of the head and neck: clinical effectiveness and prognostic value.
    Tannapfel A; Weber A
    Eur Arch Otorhinolaryngol; 2001 Feb; 258(2):83-8. PubMed ID: 11307611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.
    Ahomadegbe JC; Barrois M; Fogel S; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
    Oncogene; 1995 Mar; 10(6):1217-27. PubMed ID: 7700647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [High incidence of p53 mutations in primary and metastatic head and neck tumors. Frequent protein overexpression in normal epithelium].
    Fogel S; Ahomadegbe JC; Barrois M; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
    Bull Cancer; 1996 Mar; 83(3):227-33. PubMed ID: 8695925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.